SlidesetHIVINTEREST 2016Transmitted Drug Resistance and First-line ART Treatment Outcomes in Ugandan Children | H. MugerwaView Slideset
SlidesetHIVINTEREST 2016(Abstract) Favourable outcomes of paediatric second-line protease inhibitor-based antiretroviral treatment in Uganda | R.S. BoermaView Slideset
SlidesetHIVINTEREST 2016(Abstract) Decline in positivity rates among HIV-exposed infants with changes in PMTCT ARV regimens in Nigeria: evidence from 7 years of field implementation | H. KhamofuView Slideset
SlidesetHIVINTEREST 2016Supporting Beyond Treatment - Care for HIV Positive Adolescents | Rama DiagneView Slideset
SlidesetHIVINTEREST 2016Being Proactive - HIV Prevention in Adolescents | Magdalene MayerView Slideset
SlidesetHIVINTEREST 2016Insights and Lessons Learned on Retention, Adherence, and Achieving and Maintaining Viral Suppression: The Third 90 | Tsitsi ApolloView Slideset
SlidesetHIVINTEREST 2016Knowing Your Data - Update on the Epidemiology of HIV in Children and Adolescents | Landry TsagueView Slideset
SlidesetHIVINTEREST 2016Immediate Offer of HIV Treatment: How To Deliver on the Second 90 (including Supply Chain Management and Drug Stockouts) | Roselyn TobyView Slideset
SlidesetHIVINTEREST 2016Lessons learnt from Ebola Vaccine Trials in Emergency Settings | Godwin Enwere, MD, MScView Slideset
SlidesetHIVINTEREST 2016HIV Testing Strategies: How to Reach 90% Knowledge of Serostatus (including the role of self-testing) | Elizabeth MarumView Slideset
SlidesetHIVINTEREST 2016The Joep Lange Institute / Art and Science in the HIV response | Brandon O’DellView Slideset
SlidesetHIVINTEREST 2016Progress in HIV Prevention and Treatment Scale-Up in Sub-Saharan Africa | Claire MulangaView Slideset
